Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
HFSA 2019Adding Patiromer Allows More Spironolactone in Resistant HTN, CKDWith or without heart failure, add-on treatment with the potassium sequestrant 'enabled' more intensive use of the aldosterone blocker otherwise limited by hyperkalemia, according to the AMBER trial.
US Study Points Way to Polypill for CVD PreventionAlthough the polypill could improve adherence and reduce health inequities, little progress has been made in its implementation worldwide, particularly in the United States.
Will Renal Denervation for Hypertension Rise Again? 'There's once again excitement about renal artery denervation and…it's justified,' says one cardiologist, while another hopes for FDA approval next year, and a third is 'still not 100% convinced.'
theheart.org on Medscape, September 16, 2019
PARAGON-HF: Is There a Role for the ARNI in HFpEF?Ileana Piña quizzes investigator Burkert Pieske on the findings for sacubitril/valsartan in patients with HFpEF, including exploratory subgroup analyses and use of mineralocorticoid-receptor antagonists.
Dosing at Night to Cause BP 'Dipping'Prescribing short-term blood pressure medication could help patients achieve 'dips' overnight and reduce their risk for cardiovascular events, reports Dr George Bakris.
